Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Cancer Therapies market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Cancer Therapiesmarket, defines the market attractiveness level of Cancer Therapies market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Cancer Therapies industry, describes the types of Cancer Therapies market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cancer Therapies market and the development prospects and opportunities of Cancer Therapies industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cancer Therapies market in Chapter 13.
By Player:
Pfizer Inc
Merck & Co Inc
Bristol-Myers Squibb
Bayer AG
F Hoffmann-La Roche Ltd
Amgen
AstraZeneca
GlaxoSmithKline PLC
Novartis AG
Johnson & Johnson
By Type:
Immunological and Vaccine Approaches
Antiproliferative Approaches
Photodynamic Therapy
Gene Therapy Approaches
Cell Cycle and Apoptosis Approaches
By End-User:
Hospital Use
Clinic Use
Household
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Cancer Therapies Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Cancer Therapies Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Cancer Therapies Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Cancer Therapies Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Cancer Therapies Market Analysis and Outlook to 2022
-
7.1 Global Cancer Therapies Consumption (2017-2022)
-
7.2 United States Cancer Therapies Consumption (2017-2022)
-
7.3 Europe Cancer Therapies Consumption (2017-2022)
-
7.4 China Cancer Therapies Consumption (2017-2022)
-
7.5 Japan Cancer Therapies Consumption (2017-2022)
-
7.6 India Cancer Therapies Consumption (2017-2022)
-
7.7 South Korea Cancer Therapies Consumption (2017-2022)
8 Region and Country-wise Cancer Therapies Market Analysis and Outlook to 2028
-
8.1 Global Cancer Therapies Consumption Forecast (2022-2028)
-
8.2 United States Cancer Therapies Consumption Forecast (2022-2028)
-
8.3 Europe Cancer Therapies Consumption Forecast (2022-2028)
-
8.4 China Cancer Therapies Consumption Forecast (2022-2028)
-
8.5 Japan Cancer Therapies Consumption Forecast (2022-2028)
-
8.6 India Cancer Therapies Consumption Forecast (2022-2028)
-
8.7 South Korea Cancer Therapies Consumption Forecast (2022-2028)
9 Global Cancer Therapies Market Outlook by Types and Applications to 2022
-
9.1 Global Cancer Therapies Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Immunological and Vaccine Approaches Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Antiproliferative Approaches Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Photodynamic Therapy Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Gene Therapy Approaches Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Cell Cycle and Apoptosis Approaches Consumption and Growth Rate (2017-2022)
-
9.2 Global Cancer Therapies Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Use Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Use Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Household Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Global Cancer Therapies Market Outlook by Types and Applications to 2028
-
10.1 Global Cancer Therapies Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Immunological and Vaccine Approaches Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Antiproliferative Approaches Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Photodynamic Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Gene Therapy Approaches Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Cell Cycle and Apoptosis Approaches Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Cancer Therapies Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Use Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Use Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Household Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Cancer Therapies Import and Export Analysis (Top 5 Countries)
-
11.1 Global Cancer Therapies Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Cancer Therapies Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Cancer Therapies Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Cancer Therapies Market Competitive Analysis
-
14.1 Pfizer Inc
-
14.1.1 Pfizer Inc Company Details
-
14.1.2 Pfizer Inc Cancer Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Pfizer Inc Cancer Therapies Product and Service
-
14.2 Merck & Co Inc
-
14.2.1 Merck & Co Inc Company Details
-
14.2.2 Merck & Co Inc Cancer Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Merck & Co Inc Cancer Therapies Product and Service
-
14.3 Bristol-Myers Squibb
-
14.3.1 Bristol-Myers Squibb Company Details
-
14.3.2 Bristol-Myers Squibb Cancer Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Bristol-Myers Squibb Cancer Therapies Product and Service
-
14.4 Bayer AG
-
14.4.1 Bayer AG Company Details
-
14.4.2 Bayer AG Cancer Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Bayer AG Cancer Therapies Product and Service
-
14.5 F Hoffmann-La Roche Ltd
-
14.5.1 F Hoffmann-La Roche Ltd Company Details
-
14.5.2 F Hoffmann-La Roche Ltd Cancer Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 F Hoffmann-La Roche Ltd Cancer Therapies Product and Service
-
14.6 Amgen
-
14.6.1 Amgen Company Details
-
14.6.2 Amgen Cancer Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Amgen Cancer Therapies Product and Service
-
14.7 AstraZeneca
-
14.7.1 AstraZeneca Company Details
-
14.7.2 AstraZeneca Cancer Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 AstraZeneca Cancer Therapies Product and Service
-
14.8 GlaxoSmithKline PLC
-
14.8.1 GlaxoSmithKline PLC Company Details
-
14.8.2 GlaxoSmithKline PLC Cancer Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 GlaxoSmithKline PLC Cancer Therapies Product and Service
-
14.9 Novartis AG
-
14.9.1 Novartis AG Company Details
-
14.9.2 Novartis AG Cancer Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Novartis AG Cancer Therapies Product and Service
-
14.10 Johnson & Johnson
-
14.10.1 Johnson & Johnson Company Details
-
14.10.2 Johnson & Johnson Cancer Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Johnson & Johnson Cancer Therapies Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Cancer Therapies
-
Figure Cancer Therapies Picture
-
Table Global Cancer Therapies Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cancer Therapies Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cancer Therapies Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Cancer Therapies Consumption by Country (2017-2022)
-
Figure United States Cancer Therapies Consumption and Growth Rate (2017-2022)
-
Table Europe Cancer Therapies Consumption and Growth Rate (2017-2022)
-
Figure China Cancer Therapies Consumption and Growth Rate (2017-2022)
-
Figure Japan Cancer Therapies Consumption and Growth Rate (2017-2022)
-
Figure India Cancer Therapies Consumption and Growth Rate (2017-2022)
-
Figure South Korea Cancer Therapies Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Therapies Consumption Forecast by Country (2022-2028)
-
Figure United States Cancer Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Cancer Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Cancer Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Cancer Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Cancer Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Cancer Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunological and Vaccine Approaches Consumption and Growth Rate (2017-2022)
-
Figure Global Antiproliferative Approaches Consumption and Growth Rate (2017-2022)
-
Figure Global Photodynamic Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Gene Therapy Approaches Consumption and Growth Rate (2017-2022)
-
Figure Global Cell Cycle and Apoptosis Approaches Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Use Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Use Consumption and Growth Rate (2017-2022)
-
Figure Global Household Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Immunological and Vaccine Approaches Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antiproliferative Approaches Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Photodynamic Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gene Therapy Approaches Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cell Cycle and Apoptosis Approaches Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Use Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Use Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Household Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Cancer Therapies Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Cancer Therapies Export by Region (Top 5 Countries) (2017-2028)
-
Table Pfizer Inc (Foundation Year, Company Profile and etc.)
-
Table Pfizer Inc Cancer Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc Cancer Therapies Product and Service
-
Table Merck & Co Inc (Foundation Year, Company Profile and etc.)
-
Table Merck & Co Inc Cancer Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co Inc Cancer Therapies Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Cancer Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Cancer Therapies Product and Service
-
Table Bayer AG (Foundation Year, Company Profile and etc.)
-
Table Bayer AG Cancer Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer AG Cancer Therapies Product and Service
-
Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche Ltd Cancer Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Ltd Cancer Therapies Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Cancer Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Cancer Therapies Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Cancer Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Cancer Therapies Product and Service
-
Table GlaxoSmithKline PLC (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline PLC Cancer Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline PLC Cancer Therapies Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Cancer Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Cancer Therapies Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Cancer Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Cancer Therapies Product and Service
-
